GlassScriptPhysician profile
Andrea Johnson
NPI 1699862524
$1,046.04
in general payments reported to CMS, 2019-2025
16 companies · $69.12 in 2025
The $69.12 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.57 · 2020: $120 · 2021: $215 · 2022: $100 · 2023: $330 · 2024: $153 · 2025: $69.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $329.68 | 2023-2025 | Veozah |
| Abbvie INC. | $175.63 | 2020-2023 | |
| Mayne Pharma Commercial LLC | $144.18 | 2022-2023 | |
| Hologic Sales and Service, LLC | $75.03 | 2019-2021 | |
| Exeltis, USA INC. | $58.81 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $51.95 | 2022-2025 | Gardasil 9 |
| Aspira Women'S Health INC | $47.00 | 2021 | |
| Lupin INC. | $27.52 | 2019-2021 | |
| Viiv Healthcare Company | $23.22 | 2024 | Rukobia |
| Millicent US INC | $23.17 | 2025 | Femlyv |
| Phadia US INC. | $17.83 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.89 | 2021 | |
| Allergan, INC. | $15.23 | 2019 | |
| Scynexis, INC. | $15.05 | 2022 | |
| Avion Pharmaceuticals | $13.97 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dysis Medical, INC. | $11.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.